Pabla Cataldo, Franco Appiani, Christian Dauvergne, Óscar Cuevas, Manuel Duarte, Camila Hernández, Christian Garrido, Jorge Sandoval
{"title":"心脏移植患者的三尖瓣反流：经皮处理。","authors":"Pabla Cataldo, Franco Appiani, Christian Dauvergne, Óscar Cuevas, Manuel Duarte, Camila Hernández, Christian Garrido, Jorge Sandoval","doi":"10.4067/s0034-98872024000300395","DOIUrl":null,"url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) is the most frequent valvular complication after heart transplantation with different clinical sequelae. In its most severe form, it can cause right heart failure with a poor long-term prognosis. Its management is complex, both medical, surgical, and percutaneous. The TricValve system, a bicaval system with two self-expanding valves (superior vena cava and inferior vena cava), dedicated to treating symptomatic IT refractory to medical therapy, is safe and effective in improving quality of life. We present the first heart transplant patient with severe symptomatic TR who underwent successful bicaval valve (TricValve) implantation.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"152 3","pages":"395-400"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tricuspid Regurgitation in a Patient with Heart Transplant: Percutaneous Management.\",\"authors\":\"Pabla Cataldo, Franco Appiani, Christian Dauvergne, Óscar Cuevas, Manuel Duarte, Camila Hernández, Christian Garrido, Jorge Sandoval\",\"doi\":\"10.4067/s0034-98872024000300395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tricuspid regurgitation (TR) is the most frequent valvular complication after heart transplantation with different clinical sequelae. In its most severe form, it can cause right heart failure with a poor long-term prognosis. Its management is complex, both medical, surgical, and percutaneous. The TricValve system, a bicaval system with two self-expanding valves (superior vena cava and inferior vena cava), dedicated to treating symptomatic IT refractory to medical therapy, is safe and effective in improving quality of life. We present the first heart transplant patient with severe symptomatic TR who underwent successful bicaval valve (TricValve) implantation.</p>\",\"PeriodicalId\":101370,\"journal\":{\"name\":\"Revista medica de Chile\",\"volume\":\"152 3\",\"pages\":\"395-400\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista medica de Chile\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4067/s0034-98872024000300395\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Chile","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4067/s0034-98872024000300395","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
三尖瓣反流（TR）是心脏移植术后最常见的瓣膜并发症，具有不同的临床后遗症。最严重的三尖瓣反流可导致右心衰竭，长期预后不良。其治疗非常复杂，包括内科、外科和经皮治疗。TricValve系统是一种双腔系统，带有两个自动扩张瓣膜（上腔静脉和下腔静脉），专门用于治疗药物治疗难治的症状性IT，在改善生活质量方面安全有效。我们介绍了第一例成功植入双腔静脉瓣膜（TricValve）的严重症状性 IT 的心脏移植患者。
Tricuspid Regurgitation in a Patient with Heart Transplant: Percutaneous Management.
Tricuspid regurgitation (TR) is the most frequent valvular complication after heart transplantation with different clinical sequelae. In its most severe form, it can cause right heart failure with a poor long-term prognosis. Its management is complex, both medical, surgical, and percutaneous. The TricValve system, a bicaval system with two self-expanding valves (superior vena cava and inferior vena cava), dedicated to treating symptomatic IT refractory to medical therapy, is safe and effective in improving quality of life. We present the first heart transplant patient with severe symptomatic TR who underwent successful bicaval valve (TricValve) implantation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
